Hamostaseologie 2010; 30(04): 230-235
DOI: 10.1055/s-0037-1619054
Übersichtsarbeit
Schattauer GmbH

Identifizierung von Risikogenen für den Herzinfarkt durch genomweite Assoziationsstudien

Identification of risk genes for myocardial infarction by genome wide association studies
P. Linsel-Nitschke
1   Medizinische Klinik II, Universität zu Lübeck
,
J. Erdmann
1   Medizinische Klinik II, Universität zu Lübeck
,
H. Schunkert
1   Medizinische Klinik II, Universität zu Lübeck
› Author Affiliations
Further Information

Publication History

Publication Date:
28 December 2017 (online)

Summary

Myocardial infarction (MI) shows a strong heritability. For a long time the identification of responsible genes has been rather unsuccessful. However, with the advent of genome wide association studies (GWAS) using DNA-array technology a number of significant loci for MI have been identified which were widely replicated. Interestingly, only a small fraction of the hitherto identified genes is also associated with classical risk factors for MI such as hypercholesterolemia or diabetes. Therefore it can be concluded that the MI risk mediated by the newly identified genes involves a number of novel pathophysiological mechanisms.

This review summarizes the present state of knowledge in the field and tries to give a perspective on how these findings can be translated into clinical practice and further scientific discovery. Special consideration is given to the association of MI risk with genetic variants in the hemostatic system.

Zusammenfassung

Der Herzinfarkt hat eine starke erbliche Komponente. Die Aufschlüsselung der verantwortlichen Gene gestaltete sich allerdings lange Zeit sehr schwierig. Erst genomweite Assoziationsstudien (GWAS), die mittels DNA-Chip Technologie ermöglicht wurden, konnten eine größere Zahl von genetischen Varianten identifiziert, die inzwischen in zahlreichen Kohorten belastbar repliziert wurden. Interessanterweise wirkt nur ein kleiner Teil der bisher identifizierten Varianten über klassische Risikofaktoren (z. B. Lipide). Die Ergebnisse der GWAS lassen daher auf zahlreiche bislang unbekannte Pathomechanismen für den Herzinfarkt schließen.

Diese Arbeit fasst den Stand dieser Forschung zusammen und gibt einen Ausblick, wie die neuen Erkenntnisse diagnostisch und therapeutisch nutzbar gemacht werden können. Eine besondere Berücksichtigung findet der Zusammenhang von genetischen Varianten in Genen des hämostatischen Systems mit dem Herzinfarkt.

 
  • Literatur

  • 1 Broeckel U, Hengstenberg C, Mayer B. et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002; 30: 210-214.
  • 2 Mayer B, Erdmann J, Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol 2007; 96: 1-7.
  • 3 Brown MS, Goldstein JL. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science 1974; 185: 61-63.
  • 4 Samani NJ, Erdmann J, Hall AS. et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443-453.
  • 5 McPherson R, Pertsemlidis A, Kavaslar N. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316: 1488-1491.
  • 6 WTCCC. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
  • 7 Saxena R, Voight BF, Lyssenko V. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316: 1331-1336.
  • 8 Buch S, Schafmayer C, Volzke H. et al. A genomewide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007; 39: 995-999.
  • 9 Helgadottir A, Thorleifsson G, Manolescu A. et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316: 1491-1493.
  • 10 Erdmann J, Grosshennig A, Braund PS. et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009; 41: 280-282.
  • 11 Trégouët DA, König IR, Erdmann J. et al. Genomewide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009; 41: 283-285.
  • 12 Consortium MIG, Kathiresan S, Voight BF, Purcell S. et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009; 41: 334-341.
  • 13 Kathiresan S, Melander O, Anevski D. et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 2008; 358: 1240-1249.
  • 14 Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 2000; 101: 235-238.
  • 15 Folkersen L, Kyriakou T, Goel A. et al. PROCARDIS. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS ONE 2009; 04: e7677.
  • 16 Cunnington MS, Koref MS, Mayosi BM. et al. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet 2010; 06: e1000899.
  • 17 Holdt LM, Beutnr F, Scholz M. et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Atheroscler Thromb Vasc Biol 2010; 30: 620-627.
  • 18 Yoshikawa A, Satoh T, Tamura T. et al. The M-Ras-RA-GEF-2-Rap1 pathway mediates tumor necrosis factor-alpha dependent regulation of integrin activation in splenocytes. Mol Biol Cell 2007; 18: 2949-2959.
  • 19 Nielsen MS, Jacobsen C, Olivecrona G. et al. Sortilin/ Neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem 1999; 274: 8832-8836.
  • 20 Nilsson SK, Christensen S, Raarup MK. et al. Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J Biol Chem 2008; 283: 25920-25927.
  • 21 Linsel-Nitschke P, Heeren J, Aherrahrou Z. et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 2010; 208: 183-189.
  • 22 Ye Z, Liu EH, Higgins JP. et al. Seven haemostatic gene polymorphisms in coronary disease: metaanalysis of 66 155 cases and 91 307 controls. Lancet 2006; 367: 651-658.
  • 23 Soranzo N, Spector T, Mangino M. et al. A genomewide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009; 41: 1182-1190.
  • 24 Gudbjartsson DF, Bjornsdottir US, Halapi E. et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009; 41: 342-347.
  • 25 CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor. Circulation 2010; 12: 1382-1392.